COR

COR

Cencora (COR) is a leading global pharmaceutical wholesaler distributing medications and healthcare products.
The company is a critical link in the healthcare supply chain, connecting manufacturers with pharmacies, providers, and clinics worldwide.

$349.93 +4.05 (+1.17%)

Updated: January 14, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy COR Today?

Based on a comprehensive analysis of COR, a cautious approach is recommended. The stock presents a conflicting picture.

Analysis Summary: COR's technical picture shows strong medium-term performance but indicates potential near-term consolidation as it approaches its 52-week high. Fundamentally, the company is a concern; it generates substantial revenue but is currently unprofitable, with a recent net loss and weak liquidity metrics. The valuation is highly contradictory, with metrics like an extremely high P/B ratio suggesting overvaluation, while a low P/S ratio and PEG hint at growth potential that may not be priced in. Its lower volatility is a positive, but the core issue remains its inability to translate high revenue into sustainable profits.

Recommendation: At this time, COR is not worth buying. The combination of recent profitability losses, significant liquidity challenges, and ambiguous valuation signals presents considerable risk. Investors should wait for clearer signs of a sustainable turnaround in its bottom line before considering a position. This stock is better suited for watchlist monitoring until its fundamental performance improves.

CTA Banner

COR 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis provided, here is a 12-month outlook for COR:

12-Month Outlook for COR

The primary catalyst for COR over the next year hinges on its ability to execute a operational turnaround and achieve profitability, which would validate its growth potential suggested by its low P/S ratio. However, the significant risks are substantial, including persistent net losses, weak liquidity that could constrain operations, and a highly ambiguous valuation with signs of overvaluation on key metrics like P/B. Without a clear path to sustainable earnings and given its current price near a 52-week high, the stock is likely to experience consolidation or downside pressure, making a specific target price range inappropriate; investors should await concrete fundamental improvement before establishing a position.

Wall Street Consensus

Most Wall Street analysts are optimistic about COR's 12-month outlook, with consensus target around $349.93, indicating expected upside potential.

Average Target
$349.93
18 analysts
Implied Upside
+0%
vs. current price
Analyst Count
18
covering this stock
Price Range
$280 - $455
Analyst target range
Buy Buy
12 (67%)
Hold Hold
5 (28%)
Sell Sell
1 (6%)

Bulls vs Bears: COR Investment Factors

Overall, COR has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Record Stock Performance: Stock hit all-time high at $368.08, with 9.9% gain over past month.
  • Strong Analyst Upgrades: JP Morgan raised price target to $417, Mizuho also increased target.
  • Dividend Outperformance: Included among dividend stocks that outperform the S&P 500.
  • Sustained Growth Momentum: Stock has delivered 236% returns over the past five years.
Bearish Bearish
  • Recent Analyst Downgrade: Analysts downgraded stock to hold, causing 4.3% single-day drop.
  • Insider Selling Activity: CEO sold $1.86 million in stock, potentially signaling valuation concerns.
  • Valuation Concerns: Questions arise whether stock is overvalued after strong multi-year run.
  • Market Volatility: Stock showed significant intraday swings despite overall bullish trend.
Reward Banner

COR Technical Analysis

Overall Assessment: COR has demonstrated strong medium-term performance with substantial 3-month gains of 10.11%, significantly outpacing the broader market by 6.74%, though recent momentum has moderated with just a 0.4% gain over the past month.

Short-term Performance: While the 3-month performance markedly outperforms the market, the modest 1-month gain of 0.4% suggests near-term consolidation or deceleration in upward momentum, indicating potential stabilization after the strong quarterly advance.

Current Position: Trading at $345.88 places COR approximately 80% toward the upper end of its 52-week range ($235.77-$377.54), suggesting the stock is approaching overbought territory though still below its recent peak, warranting caution for new long positions given its proximity to the yearly high.

šŸ“Š Beta
0.67
0.67x market volatility
šŸ“‰ Max Drawdown
-10.5%
Largest decline past year
šŸ“ˆ 52-Week Range
$236-$378
Price range past year
šŸ’¹ Annual Return
+47.2%
Cumulative gain past year
Period COR Return S&P 500
1m +1.1% +1.3%
3m +10.0% +5.7%
6m +16.6% +10.6%
1y +47.2% +16.5%
ytd +3.3% +1.1%

COR Fundamental Analysis

Revenue & Profitability COR generated substantial quarterly revenue of $83.7 billion in Q4 2025 but reported a net loss of -$339.7 million, yielding a negative net profit margin of -0.41%. This contrasts sharply with the prior quarter's net income of $687.4 million, indicating significant volatility in profitability driven by substantial other expenses.

Financial Health The company maintains a low debt ratio of 10.0% but faces liquidity challenges with a current ratio below 1 (0.90) and a weak cash ratio of 0.08. Operating cash flow coverage remains adequate at 0.41 times debt, though interest coverage is concerning at just 0.24 times.

Operational Efficiency COR demonstrates strong asset utilization with an asset turnover of 1.09, but operational performance is undermined by a deeply negative return on equity (-22.5%) and minimal operating margins. The negative ROCE (0.10%) further reflects inefficiency in generating returns from capital employed.

Quarterly Revenue
$83.7B
2025-09
Revenue YoY Growth
+5.9%
YoY Comparison
Gross Margin
3.5%
Latest Quarter
Free Cash Flow
$-1.1B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is COR Overvalued?

Valuation Level: COR presents contradictory signals with elevated valuation ratios including a TTM PE of 42.34 and extremely high PB of 37.99, suggesting potential overvaluation based on earnings and book value. However, the unusually low PS ratio of 0.21 and reasonable PEG of 0.30 indicate potential undervaluation when considering revenue growth prospects, while the exceptionally high EV/EBITDA of 427 highlights significant operational challenges or extraordinary circumstances affecting cash flow generation.

Peer Comparison: Without industry average data available, definitive comparative analysis cannot be established. The valuation metrics suggest COR operates in a specialized sector where traditional benchmarks may not apply, requiring consideration of company-specific growth trajectories and business model characteristics rather than standardized industry comparisons for accurate assessment.

Current PE
42.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -45Ɨ-3303Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
427.3x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility risk appears moderate, as indicated by a beta of 0.665, suggesting the stock is less volatile than the broader market. The one-year maximum drawdown of -10.52% demonstrates relatively restrained downside movement during periods of market stress.

Regarding other risks, the absence of short interest signals minimal bearish speculation and low perceived downside risk from this metric. Liquidity and other risks would require further data but the lack of short interest generally points to favorable sentiment.

FAQs

Is COR a good stock to buy?

Neutral to slightly bearish based on current levels. While COR shows strong revenue growth and bullish analyst sentiment, the stock trades near 52-week highs with negative profitability metrics and valuation concerns (PE 42, PB 38). Recent insider selling and mixed technical momentum suggest limited near-term upside. Suitable only for growth-oriented investors comfortable with volatility and able to tolerate profitability challenges.

Is COR stock overvalued or undervalued?

Based on the metrics provided, COR appears overvalued due to its poor profitability profile despite some attractive growth indicators. Key metrics like the extremely high PE (42.34) and PB (37.99) ratios are concerning, though the low PS ratio (0.21) and PEG ratio (0.30) suggest growth potential. The fundamental problem is that these growth expectations are disconnected from current reality - the company is unprofitable (negative net margin, negative ROE) and has weak cash flow generation (extremely high EV/EBITDA of 427). Given the absence of current profits and questionable financial health, the stock appears priced for perfection that the fundamentals don't support.

What are the main risks of holding COR?

Based on the provided information, here are the key risks of holding COR stock, ordered by importance:

1. Profitability Volatility Risk: The company's sudden swing from a $687.4 million net income to a -$339.7 million net loss in consecutive quarters indicates high earnings instability and poses a significant threat to its valuation. 2. Severe Liquidity Risk: With a current ratio below 1 (0.90) and an extremely weak cash ratio (0.08), the company faces a material risk of being unable to meet its short-term obligations. 3. Valuation and Momentum Risk: The stock is trading near the top of its 52-week range after a strong rally, suggesting limited near-term upside and elevated risk of a price correction, especially as recent momentum has stalled.

What is the price forecast for COR in 2026?

Based on the provided aggressive growth profile but significant profitability and liquidity challenges, here is a strategic forecast for COR for 2026:

Our base case target for 2026 is $300-$350, reflecting consolidation from its current peak as the market demands proof of sustainable profitability. A bull case of $400+ is contingent on COR successfully executing its operational turnaround to achieve consistent net income. The key growth drivers are its massive revenue scale ($83.7B quarterly) and high asset turnover (1.09), but these are offset by critical assumptions of improved cost controls and resolved liquidity issues. This forecast carries high uncertainty due to the company's deeply negative ROE (-22.5%) and volatile earnings, making its path to justifying its valuation highly speculative.